- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 105.57M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $219M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $256M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.14B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.12B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $460M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $442M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $507M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $493M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.07B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.65B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.62B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 107.35M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1M |
| Capex | Q1 2025 · Mar 31, 2024 | $1M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $81M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.20 |
| Net Income | Q1 2025 · Mar 31, 2024 | $21M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $28M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $434M |
| Revenue | Q1 2025 · Mar 31, 2024 | $563M |